Antidotes for the new oral anticoagulants: Reality and expectations

被引：0
|
作者：
Gomez-Outes, Antonio [1 ]
Lecumberri, Ramon [2 ]
机构：
[1] AEMPS, Div Farmacol & Evaluac Clin, Madrid, Spain
[2] Univ Navarra Clin, Serv Hematol, Pamplona, Navarra, Spain
来源：
MEDICINA CLINICA | 2016年 / 146卷 / 11期
关键词：
ATRIAL-FIBRILLATION PATIENTS; INTRACRANIAL HEMORRHAGE; DABIGATRAN; MANAGEMENT; IDARUCIZUMAB; WARFARIN; TOLERABILITY; VOLUNTEERS; INHIBITORS; REVERSAL;
D O I：
10.1016/j.medcle.2015.11.031
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：488 / 490
页数：3
相关论文
共 50 条
  • [41] New Oral Anticoagulants
    Paje, David
    Kaatz, Scott
    HOSPITAL MEDICINE CLINICS, 2013, 2 (03) : E456 - E471
  • [42] The new oral anticoagulants
    Verheugt, F. W. A.
    NETHERLANDS HEART JOURNAL, 2010, 18 (06): : 314 - 318
  • [43] The new oral anticoagulants
    Garcia, David
    Libby, Edward
    Crowther, Mark A.
    BLOOD, 2010, 115 (01) : 15 - 20
  • [44] New oral anticoagulants
    Galanis, Taki
    Thomson, Lynda
    Palladino, Michael
    Merli, Geno J.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 31 (03) : 310 - 320
  • [45] New oral anticoagulants
    Lozano, F. S.
    Arcelus, J. I.
    Monreal, M.
    ANGIOLOGIA, 2010, 62 (01): : 26 - 32
  • [46] NEW ORAL ANTICOAGULANTS Safety of new oral anticoagulants in high risk patients
    Dalgleish, Stephen
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [47] Old and new anticoagulants - Antidotes and measures for acute hemorrhaging and urgent interventions
    Lance, M.
    Stessel, B.
    Hamulyak, K.
    Marcus, M. A.
    ANAESTHESIST, 2010, 59 (01): : 62 - 68
  • [48] Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data
    Tummala, Ramyashree
    Kavtaradze, Ana
    Gupta, Anjan
    Ghosh, Raktim Kumar
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 214 : 293 - 299
  • [49] Why develop antidotes and reversal agents for non-vitamin K oral anticoagulants?
    Jeffrey B. Washam
    Jonathan P. Piccini
    Journal of Thrombosis and Thrombolysis, 2016, 41 : 279 - 284
  • [50] Antidotes for anticoagulants: a long way to go
    Treschan, Tanja A.
    Beiderlinden, Martin
    LANCET, 2015, 386 (9994): : 634 - 636
12345